Progression Patterns of Choroidal Venous Alterations

NCT ID: NCT07236671

Last Updated: 2025-11-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-03-04

Study Completion Date

2029-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is about understanding how a condition called pachychoroid changes over time. Pachychoroid refers to an anatomic choroidal characteristic with abnormally thick choroid or abnormally dilated Haller's vessels. Pachychoroid can range from mild forms which does not cause any problems to more serious ones that might cause vision loss.This study will recruit participants with pachychoroid, to learn more about how this condition develops, how it affects people in the long run, and what factors might make it worse.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to document the longitudinal progression pattern and the incidence rate of progression of choroidal venous alteration (defined as either an increase in number of quadrants with pachyvessels or formation of new anastomoses which violates the physiological watershed It will provide valuable natural history data to study the pattern of evolution of choroidal vessels over time and validate the proposed multi-hit theory over a period of three years.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pachychoroid Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adults aged 45 years or older.
2. Presence of pachyvessels on ultra-widefield (UWF) imaging in at least one quadrant.
3. Willing to undergo pupil dilation, and protocol-required procedures for both eyes
4. Willing to provide written informed consent

Exclusion Criteria

1. Presence of disorders of the ocular media which interfere with visual acuity and other ocular assessments during the study period
2. Eyes with other ocular pathology such as trauma, inflammation, previous intraocular surgery (except for cataract surgery)
3. Systemic diseases that might affect ocular blood flow such as uncontrolled hypertension, autoimmune disease, and haematological disorders
4. Pregnant or nursing women
5. Persons who are unable to give informed consent
Minimum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National University Hospital, Singapore

OTHER

Sponsor Role collaborator

University of Malaya

OTHER

Sponsor Role collaborator

Hong Kong University

OTHER

Sponsor Role collaborator

Singapore National Eye Centre

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gemmy Cheung Chui Ming

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hong Kong University

Hong Kong, , Hong Kong

Site Status NOT_YET_RECRUITING

University of Malaya Medical Centre

Kuala Lumpur, , Malaysia

Site Status RECRUITING

National University Hospital, Singapore

Singapore, , Singapore

Site Status NOT_YET_RECRUITING

Singapore National Eye Centre/ Singapore Eye Research Institute

Singapore, , Singapore

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Hong Kong Malaysia Singapore

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gemmy Cheung

Role: CONTACT

+65 63227460

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Angie Fong

Role: primary

852 2518 1430

Lott Pooi Wah Dr

Role: primary

03-79677022

Wendy Wong

Role: primary

Gemmy Cheung

Role: primary

+65 63227460

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-4359

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.